Substance Use Disorder

Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.

Use this protocol, presented at the 2024 APA Annual Meeting, in patients with cannabis use disorder to bolster likelihood of cannabis cessation or reduction in use.

A look at the theme for the 2024 American Psychiatric Association Annual Meeting.

How can psychiatric clinicians improve outcomes for this unique patient population?

How can novel technologies help address stigma and improve care for patients with SUDs?

"In the face of such a pervasive crisis, being present for those with addiction can ignite hope and foster healing."

What are the most effective approaches to SUD treatment in this unique patient population?

Explore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.

How can telehealth aid in the treatment of opioid use disorders in this patient population?

Take a look back at our recent coverage relating to our April content theme.

Write to us now to be part of our series focused on addiction and substance use disorders this month.

Here are some updates from the world of psychiatry throughout the month of February.

Neuropsychiatric disorders regularly occur following traumatic brain injury and are often diagnosed within the first year postinjury. Diagnosis and treatment of neuropsychiatric disorders can be difficult due to a number of interacting factors, such as preinjury psychiatric history, lesion location, injury severity, substance misuse, and psychosocial complications. Clinicians should use a highly individualized approach to diagnosis and treatment planning.

Psychiatric Times® Substance Use Section Editor Roueen Rafeyan, MD, DFAPA, FASAM, weighs in.

From pain and suicidality in patients with depression to digital mental health interventions for adolescents with eating disorders, here are highlights from the week in Psychiatric Times.

The grant programs are aimed at supporting treatment services for pregnant and postpartum individuals and individuals involved in treatment drug courts.

The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.

From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.

In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.

From substance use disorders in physicians to new research on the efficacy of MDMA-assisted therapy for PTSD, here are highlights from the week in Psychiatric Times.

What is new in research on posttraumatic stress disorder?

What is new in research on schizophrenia?